
Opinion|Videos|August 15, 2023
CheckMate 9ER: Quality of Life Data and Treatment Implications in Advanced RCC
Author(s)Rana R. McKay, MD
Expert perspective on CheckMate 9ER quality of life data and treatment implications for patients with advanced RCC.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Accepts BLA for Ivonescimab in Pretreated EGFR-Mutated NSCLC
2
The Targeted Pulse: New Standards in Myeloma, Melanoma, and More
3
Onvansertib Triplet Shows Dose-Dependent Frontline Benefit in RAS-Mutant Metastatic CRC
4
Pembrolizumab/Lenvatinib Show Efficacy, Safety in Clear Cell Gyn Cancers
5



















